Host a CF clinical trial in Canada
As a centralized network of paediatric and adult cystic fibrosis trial sites across the country, Cystic Fibrosis Canada Accelerating Clinical Trials Network (CF CanACT), removes barriers and provides the infrastructure and support required for sponsors to conduct trials in Canada.

Trusted leaders in CF clinical trials
Since inception in 2018, CF CanACT has led CF clinical trials across the country. This nimble network of 10 adult and pediatric clinic-affiliated sites at 13 clinics covers 61% of Canadians with CF and is supported by experience on-site research coordinators for rapid trial start-up, execution and successful trial completion. Through a national referral program, sponsors gain access to 100% of the 4,500+ CF patients in Canada across 27 CF clinics, enabling broad recruitment.
Cross-Canada Representation
CF CanACT 2024 Year-in-Review
2024 Trial Participation
2600+ participants to date
7 industry-sponsored trials
85 patients enrolled in interventional clinical trials
3 observational trials
2024 Firsts
First multi-centre investigator-initiated protocol review conducted by CF CanACT
First NABT trials in the network launched
First pediatric pharmacokinetics study launched by the network
Protocol Reviews 2024
3 independent Canada-only reviews
6 collaborative global reviews
The process
Our benchmark timelines help to ensure your clinical trial gets moving as quickly as possible:
STEP ONE
Key issues table and critique summary returned to Sponsor within 14 days of submission
STEP TWO
Executive committee (EC) decides on sanctioning and internalstrategic fit score within 5 days of Sponsor response to key issues
STEP THREE
Sponsor may choose to accept or appeal the EC’s sanctioning decision
Support referrals
CF CanACT has a well-established referral process to ensure that your trial is well-positioned to meet recruitment targets, no matter where eligible patients are located. CF CanACT also has established relationships with CF clinics that are not affiliated with the research network, which allows patients to be referred into trials happening with CF CanACT from anywhere in Canada.